Glioblastoma Multiforme Patients in Clinical Trials: An Examination of Their Clinical Trial Experiences
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 500
- 试验地点
- 1
- 主要终点
- Rate of patients who decide to enroll in a glioblastoma multiforme clinical study.
研究概览
简要总结
Clinical research can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical study, both positive and negative.
The goal is to identify the obstacles and challenges that prevent participation in glioblastoma multiforme clinical study, as well as the reasons for withdrawal or discontinuation.
Insights gained from this study will ultimately benefit those with glioblastoma multiforme who may be invited to participate in clinical trial in the years to come.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Crossover
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of glioblastoma multiforme
- •No prior treatment for glioblastoma multiforme
- •Ability to understand and the willingness to sign a written informed consent document.
排除标准
- •Female patients who are currently pregnant or nursing
- •Enrolled in another research study
- •Patients who are currently receiving any other investigational drug.
结局指标
主要结局
Rate of patients who decide to enroll in a glioblastoma multiforme clinical study.
时间窗: 3 months
Number of glioblastoma multiforme study participants who remain in clinical trial until completion.
时间窗: 12 months
次要结局
未报告次要终点